MARSHALL MEDICAL CENTER — History
CCN 441309 | 3-year financial timeline | COVID resilience: 44/100
🛡️ Public data only — no PHI permitted on this instance.
$29M
Latest Revenue (FY2022)
+8.3%
Revenue CAGR (3yr)
-28.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $25M | $30M | $29M | -2.5% | +8.3% |
| Operating Expenses | $29M | $32M | $38M | +18.2% | +14.9% |
| Operating Margin | -13.6% | -5.6% | -28.0% | -398.7% | +0.0% |
| Net Income | $-3M | $-2M | $-8M | -386.4% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 1,937 | 1,991 | 1,795 | -9.8% | -3.7% |
| Medicare Day % | 54% | 47% | 62% | +33.6% | +7.7% |
| Medicaid Day % | nan% | 2% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 44/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +17.3% ($25M → $29M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+8.3%
This Hospital
+7.6%
State Avg
Latest Margin
-28.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $32M | -35.1% |
| FY2024 (proj) | $34M | -42.3% |
| FY2025 (proj) | $36M | -49.5% |